Glucose Lowering Therapeutic Strategies for Type 2 Diabetic Patients with Chronic Kidney Disease in Primary Care Setting in France: A Cross-Sectional Study
Table 1
Patient demographics and disease characteristics.
Characteristics
Group 1
Group 2
Age in years
N = 86
N = 211
Mean (SD)
76.2 (±11.3)
75.8 (±10.5)
Gender ratio
N = 86
N = 211
(M/F)
1.9
0.7
BMI (kg/m²)
N = 86
N = 207
Mean (SD)
28.2 (±4.8)
29.3 (±5.5)
BMI (kg/m²): N patients (%) with
N = 86
N = 211
BMI < 25
25 (29%)
44 (21%)
25 ≤ BMI < 30
35 (41%)
81 (39%)
BMI ≥ 30
26 (30%)
82 (40%)
GFR (mL/min/1.73 m²)
N = 86
N = 211
Mean (SD)
51.9 (±4.3)
29.41 (±13.0)
Time since CKD diagnosis: N patients (%)
≥1 year
N = 85 66 (77%),
N = 207 175 (83%)
≤1 year
N = 84 20 (23%)
N = 203 36 (17%)
Proteinuria: N patients (%) with
Microproteinuria
39 (46%)
124 (60%)
Macroproteinuria
7 (8%)
38 (19%)
Time since diabetes diagnosis (years)
N = 86
N = 2011
Mean (SD)
12.6 (±8.4)
14.2 (±9.0)
HbA1c
N = 76
N = 197
Percentage (SD)
7.2 (±1.1)
7.1 (±1.3)
HbA1c < 7%
N = 76
N = 197
N patients (%)
36 (47%)
106 (54%)
N:number of patients, BMI: body mass index; CKD: chronic kidney disease; GFR: glomerular filtration rate; SD: standard deviation.
